24.38

2.05% -0.46

After Hours: 24.40 0.02 +0.08%

Bioage Labs Inc (BIOA)

Overview News Price History Discussions Forecast

Bioage Labs Inc stock is traded at $24.38, with a volume of 383.35K. It is down -2.05% in the last 24 hours and up +54.97% over the past month. Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Previous Close:

$24.84

Open:

$24.88

24h Volume:

383.35K

Relative Volume:

0.79

Market Cap:

$1.08B

Revenue:

$10.32M

Net Income/Loss:

$-89.93M

P/E Ratio:

-10.13

EPS:

-2.4064

Net Cash Flow:

$-88.63M

1W Performance:

-0.73%

1M Performance:

+54.97%

6M Performance:

+63.18%

1Y Performance:

+482.06%

1-Day Range:

$23.39

$24.93

1-Week Range:

$23.39

$25.95

52-Week Range:

$4.11

$25.95

Bioage Labs Inc Stock (BIOA) Company Profile

Name

Bioage Labs Inc

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

510-806-1445

Address

5885 HOLLIS STREET, EMERYVILLE

Employee

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

BIOA's Discussions on Twitter

Compare BIOA vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIOA Bioage Labs Inc	24.39	1.10B	10.32M	-89.93M	-88.63M	-2.4064
TAK Takeda Pharmaceutical Co Adr	16.96	53.37B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.84	42.80B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.65	41.09B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.29	31.62B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	563.70	23.23B	3.17B	1.29B	1.01B	27.09

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-27-26	Initiated	Needham	Buy
Feb-25-26	Initiated	Oppenheimer	Outperform
Feb-18-26	Upgrade	Jefferies	Hold → Buy
Jan-27-26	Initiated	Piper Sandler	Overweight
Dec-05-25	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Oct-22-25	Upgrade	Citigroup	Neutral → Buy
Feb-28-25	Initiated	William Blair	Mkt Perform
Dec-10-24	Downgrade	Morgan Stanley	Overweight → Underweight
Dec-09-24	Downgrade	Citigroup	Buy → Neutral
Dec-09-24	Downgrade	Jefferies	Buy → Hold
Oct-21-24	Initiated	Citigroup	Buy
Oct-21-24	Initiated	Jefferies	Buy
Oct-21-24	Initiated	Morgan Stanley	Overweight

View All

Bioage Labs Inc Stock (BIOA) Latest News

12:35 PM

Why BioAge Labs (BIOA) Is Up 6.3% After Starting QUELL-CV Phase 2 Trial For BGE-102 - Sahm

Jul 03, 2026

Jul 01, 2026

Form 4 Bioage Labs Inc For: 1 July By Investing.com - Investing.com Nigeria

Jul 01, 2026

BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: - GuruFocus

Jul 01, 2026

Bioage Labs Insider Sold Shares Worth $1,576,752, According to a Recent SEC Filing - Moomoo

Jul 01, 2026

BioAge Labs principal accounting officer sells $1.57m in stock - Investing.com

Jul 01, 2026

BioAge Labs principal accounting officer sells $1.57m in stock By Investing.com - Investing.com South Africa

Jul 01, 2026

[Form 4] BioAge Labs, Inc. Insider Trading Activity - Stock Titan

Jul 01, 2026

Jun 30, 2026

BioAge Labs (BIOA) Q1 2026 Earnings: EPS Beat Amid Pre-Revenue Biotech Development StageMid-Term Outlook - dars.gov.et

Jun 30, 2026

BIOA (NASDAQ: BIOA) Form 144 filed for 42,350-share proposed sale - Stock Titan

Jun 30, 2026

Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation? - Yahoo Finance

Jun 30, 2026

Jun 29, 2026

Form 144 BioAge Labs For: 29 June By Investing.com - Investing.com Nigeria

Jun 29, 2026

BIOA (BIOA) Form 144 lists proposed sales of 2,632 and 39,718 shares - Stock Titan

Jun 29, 2026

BioAge Labs, Inc.(NasdaqGS: BIOA) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 29, 2026

BioAge Labs, Inc.(NasdaqGS: BIOA) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

BioAge Labs, Inc.(NasdaqGS: BIOA) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

BioAge Labs, Inc.(NasdaqGS: BIOA) added to Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

BioAge Labs, Inc.(NasdaqGS: BIOA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBIT forward of BioAge Labs, Inc. – NASDAQ:BIOA - TradingView

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBIT forward of BioAge Labs, Inc. – GETTEX:Y7G - TradingView

Jun 26, 2026

BioAge Labs (BIOA) Tests BGE-102 in Phase 2 Trial, But What Does It Signal Strategically? - Sahm

Jun 26, 2026

BioAge Labs, Inc. Actuals & Estimates (NASDAQ:BIOA) - TradingView

Jun 26, 2026